Posaconazole

FDA Approved: * December 26, 2023
Pharm Company: * MYLAN LABS LTD
Category: Antifungal

Posaconazole, sold under the brand names Noxafil and Posanol is a triazole antifungal medication.[2][3] It was approved for medical use in the United States in September 2006,[4] and is available as a generic medication.[5] Contents 1 Medical uses 2 Pharmacology 2.1 Pharmacodynamics 2.1.1 Microbiology 2.2 Pharmacokinetics 3 References 4 External links Medical uses Posaconazole is used to treat invasive Aspergillus an... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Posaconazole 100
Posaconazole 100 mg Oral Tablet, Delayed Release
NDC: 60687-523
Labeler:
American Health Packaging
Posaconazole 100
Posaconazole 100 mg Oral Tablet, Coated
NDC: 0254-2045
Labeler:
Par Pharmaceutical Inc.
Posaconazole 100
Posaconazole 100 mg Oral Tablet, Delayed Release
NDC: 0527-2133
Labeler:
Lannett Company Inc.
Posaconazole 40 mg/ml Oral Suspension
NDC: 0054-0449
Labeler:
Hikma Pharmaceuticals USA Inc.
Posaconazole 40 mg/ml Oral Suspension
NDC: 0254-1016
Labeler:
Par Pharmaceutical Inc.
Posaconazole 100 mg Oral Tablet, Delayed Release
NDC: 0406-7711
Labeler:
Specgx LLC
Posaconazole 100 mg Oral Tablet, Delayed Release
NDC: 0904-7149
Labeler:
Major Pharmaceuticals
Posaconazole 100 mg Oral Tablet, Delayed Release
NDC: 16714-156
Labeler:
Northstar Rxllc
Posaconazole 100 mg Oral Tablet, Delayed Release
NDC: 16714-535
Labeler:
Northstar Rxllc
Posaconazole 100 mg Oral Tablet, Delayed Release
NDC: 17856-2133
Labeler:
Atlantic Biologicals Corp.
More Results

Related Brands

Drugs with the same active ingredients